When fetal cardiac rhabdomyoma is identified via prenatal ultrasound, TSC1/TSC2 gene testing should be incorporated into routine evaluations to differentiate hereditary TSC from sporadic cardiac tumors. The gene discussed is TSC2; the disease is heart neoplasm.